Table 3.
Antimicrobial susceptibility profile of Gram-positive isolates patients with external ocular infection at UoGCSH, from May 1 to July 30, 2023
| Isolates | Susceptibility pattern | AMP | CXT | SXT | CAF | E | CN | TE | CIP | DA | CRO |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
S.aureus (97) |
R I S |
75(77.3) 2(2.0) 20(20.6) |
21(21.6) 0 76(78.4) |
19(19.6) 3(3.1) 75(77.3) |
8(8.2) 0 89(91.8) |
49(50.5) 0 48(49.5) |
11(11.3) 0 86(88.7) |
73(75.3) 5(5.2) 19(19.6) |
12(12.4) 0 85(87.6) |
10(10.3) 0 87(89.7) |
16(16.5) 3(3.1) 78(80.4) |
|
CoNS (66) |
R I S |
46(69.7) 2(3.03) 18(27.3) |
37(56.1) 0 29(43.9) |
14(21.2) 0 52(78.8) |
7(10.6) 0 59(89.4) |
45(68.2) 0 21(31.8) |
16(24.2) 0 50(75.8) |
50(75.8) 1(1.5) 15(22.7) |
27(40.9) 0 39(59.1) |
7(10.6) 0 59(89.4) |
36(54.5) 0 30(45.5) |
|
S.pneumoniae (5) |
R I S |
3(60) 0 2(40) |
NA |
3(60) 0 2(40) |
0 0 5(100) |
1(20) 0 4(80) |
NA |
3(60) 0 2(40) |
NA |
0 0 5(100) |
NA |
|
Total isolate N = 168 |
R I S |
124(73.8) 4(2.4) 40(23.8) |
58(34.5) 0 105(62.5) |
36(21.4) 3(1.8) 129(76.8) |
15(8.9) 0 153(91.1) |
95(56.5) 0 73(43.5) |
27(16.1) 0 136(81) |
126(75) 6(3.6) 36(21.4) |
39(23.2) 0 124(73.8) |
17(10.1) 0 151(89.9) |
52(31) 3(1.8) 108(64.3) |
AMP Ampicillin, CTX Cefoxitin, SXT Cotrimoxazole, CAF Chloramphenicol, E Erythromycin, CN Gentamycin, TE Tetracycline, CIP Ciprofloxacin, CRO Ceftriaxone, DA Clindamycin, NA Not applicable, S Susceptible, I Intermediate, R Resistance